Celebrating Pharmig’s 25th Annual Conference
• 3 Regulators: FDA, HPRA,MHRA and 6 leading industry experts from: Merck,P&G, LabMET, Foresight Innovations & Public Health England (PHE)
Key topics covered include:
- The Use of Rapid Microbiological Methods: An MHRA perspective
- Burkholderia cepacia Complex and Aqueous Non-sterile Drugs: A CDER Perspective
- Industry Case Study: A Microbial Investigation of Contamination by Burkholderia multivorans
- An Alternative Approach to Equipment Sanitization
- Understanding Human Error: Our Role as Ambassadors for Future Human Error Prevention
- Regulatory Updates and the Implications of Brexit Relevant to Microbiology and Industry as a Whole
- Risk Assessment and Quality Risk Management – 10 Years On and Where We Need to Go in Microbiological QRM
- The Development of thermostable Adenylate Kinase (tAK) Indicators for Decontamination Process Monitoring in Pharmaceuticals
- Changes to the USP around Sterility Testing and Parametric Release
- What Innovative ‘Eco-Microbiology’ has Potential for the Needs of the Next Decade?
For more information please visit: www.pharmig.org.uk
